Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Baxter
Healthtrust
Moodys
Merck
Mallinckrodt
Teva
Farmers Insurance

Generated: September 19, 2018

DrugPatentWatch Database Preview

ATRACURIUM BESYLATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Atracurium Besylate, and when can generic versions of Atracurium Besylate launch?

Atracurium Besylate is a drug marketed by Aurobindo Pharma Ltd, Baxter Hlthcare, Baxter Hlthcare Corp, Hospira, Hospira Inc, Mylan Labs Ltd, Nanjing King-friend, Teva Parenteral, Watson Pharms Teva, West-ward Pharms Int, and Watson Labs Inc. and is included in twenty-two NDAs.

The generic ingredient in ATRACURIUM BESYLATE is atracurium besylate. There are sixteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atracurium besylate profile page.

Drug patent expirations by year for ATRACURIUM BESYLATE
Pharmacology for ATRACURIUM BESYLATE
Medical Subject Heading (MeSH) Categories for ATRACURIUM BESYLATE

US Patents and Regulatory Information for ATRACURIUM BESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 206011-001 Apr 8, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 090782-001 Oct 18, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 206096-001 Jun 22, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira ATRACURIUM BESYLATE atracurium besylate INJECTABLE;INJECTION 074632-001 Dec 23, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ATRACURIUM BESYLATE PRESERVATIVE FREE atracurium besylate INJECTABLE;INJECTION 206010-001 Apr 8, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Baxter
Healthtrust
Moodys
Merck
Mallinckrodt
Teva
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.